Trial NCT02374424

View at ClinicalTrials.gov 
Org. Study IDs: FIL_GA101_DHAP

Last trial update was posted on 2022-06-06

MeSH Interventions

Obinutuzumab

MeSH Conditions

Lymphoma Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse, Large B-Cell, Lymphoma

Stopping Reasons

Interim analysis planned as per protocol didn't provide positive outcome therefore enrollment was not reopened. However, the enrolled patients concluded therapy and continued into the follow-up phase. The study was closed only after LVLP.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID